Correlation Between Artelo Biosciences and Aileron Therapeutics

Can any of the company-specific risk be diversified away by investing in both Artelo Biosciences and Aileron Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artelo Biosciences and Aileron Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Artelo Biosciences and Aileron Therapeutics, you can compare the effects of market volatilities on Artelo Biosciences and Aileron Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artelo Biosciences with a short position of Aileron Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artelo Biosciences and Aileron Therapeutics.

Diversification Opportunities for Artelo Biosciences and Aileron Therapeutics

-0.13

Correlation Coefficient

Artelo Biosciences  Aileron Therapeutics

Good diversification

The 3 months correlation between Artelo and Aileron is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Artelo Biosciences and Aileron Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aileron Therapeutics and Artelo Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artelo Biosciences are associated (or correlated) with Aileron Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aileron Therapeutics has no effect on the direction of Artelo Biosciences i.e., Artelo Biosciences and Aileron Therapeutics go up and down completely randomly.

Pair Corralation between Artelo Biosciences and Aileron Therapeutics

Given the investment horizon of 90 days Artelo Biosciences is expected to under-perform the Aileron Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Artelo Biosciences is 1.19 times less risky than Aileron Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Aileron Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  270.00  in Aileron Therapeutics on September 2, 2024 and sell it today you would earn a total of  16.00  from holding Aileron Therapeutics or generate 5.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Artelo Biosciences  vs.  Aileron Therapeutics

Artelo Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Aileron Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Aileron Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Aileron Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Artelo Biosciences and Aileron Therapeutics

The main advantage of trading using opposite Artelo Biosciences and Aileron Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artelo Biosciences position performs unexpectedly, Aileron Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will offset losses from the drop in Aileron Therapeutics' long position.

The idea behind Artelo Biosciences and Aileron Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.